Cardiovascular effects of inhaled ultrafine and nanosized particles [[electronic resource] /] / edited by Flemming R. Cassee, Nicholas L. Mills, David Newby |
Pubbl/distr/stampa | Hoboken, N.J., : John Wiley, c2011 |
Descrizione fisica | 1 online resource (608 p.) |
Disciplina | 616.1/2071 |
Altri autori (Persone) |
CasseeFlemming R
MillsNicholas L NewbyDavid E |
Soggetto topico |
Heart - Toxicology
Air - Pollution - Toxicology Nanoparticles - Toxicology Pulmonary toxicology |
ISBN |
0-470-92277-X
1-282-88900-1 9786612889004 0-470-91091-7 0-470-91090-9 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
CARDIOVASCULAR EFFECTS OF INHALED ULTRAFINE AND NANOSIZED PARTICLES; CONTENTS; FOREWORD; PREFACE; THE EDITORS; CONTRIBUTORS; PART I: ISSUE FRAMING; CHAPTER 1: OVERVIEW; CHAPTER 2: ACUTE EFFECTS OF PARTICULATE MATTER ON THE RISK OF MYOCARDIAL INFARCTION; CHAPTER 3: CHRONIC EFFECTS OF AIR POLLUTION ON CARDIOVASCULAR HEALTH; PART II: EXPOSURE; CHAPTER 4: PARTICLE CHARACTERIZATION; CHAPTER 5: EXPOSURE ASSESSMENT FOR AMBIENT ULTRAFINE PARTICLES; CHAPTER 6: FROM EXPOSURE TO DOSE; CHAPTER 7: TRANSLOCATION OF INHALED NANOPARTICLES
CHAPTER 8: ROLE OF CHEMICAL COMPOSITION IN DETERMINING THE CARDIOVASCULAR EFFECTS OF PARTICLESPART III: METHODOLOGY; CHAPTER 9: IN VITRO STUDIES; CHAPTER 10: EXPERIMENTAL STUDIES IN ANIMALS; CHAPTER 11: HUMAN EXPOSURE STUDIES; CHAPTER 12: PANEL STUDIES; PART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS A. ATHEROGENESIS; CHAPTER 13: PARTICULATES AND OXIDATIVE STRESS; CHAPTER 14: ROLE OF INFLAMMATION IN THE ATHEROGENIC EFFECTS OF PARTICULATE MATTER; CHAPTER 15: INHALED PARTICLES, POSTPRANDIAL LIPIDS, AND THEIR POSSIBLE CONTRIBUTION TO ATHEROGENESIS: THE TROJAN HORSE HYPOTHESIS CHAPTER 16: INHALED PARTICULATE MATTER AND ATHEROSCLEROSIS IN HUMANSPART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS B. VASCULAR DYSFUNCTION; CHAPTER 17: EFFECTS OF NANOPARTICLES ON THE PULMONARY VASCULATURE; CHAPTER 18: PARTICULATE MATTER, HYPERTENSION, AND THE METABOLIC SYNDROME; CHAPTER 19: PARTICLES AND THE VASCULAR ENDOTHELIUM; PART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS C. THROMBOSIS; CHAPTER 20: PARTICLES, COAGULATION, AND THROMBOSIS; CHAPTER 21: PARTICLES AND THE PATHOGENESIS OF ATHEROTHROMBOSIS PART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS D. ARRHYTHMIACHAPTER 22: PARTICLES AND THE AUTONOMIC NERVOUS SYSTEM; CHAPTER 23: AIR POLLUTION AND ARRHYTHMIA; PART V: ENVIRONMENTAL AND PUBLIC HEALTH POLICY; CHAPTER 24: RISK ASSESSMENT; CHAPTER 25: ENVIRONMENTAL REGULATION OF PARTICULATE MATTER; CHAPTER 26: FROM AMBIENT ULTRAFINE PARTICLES TO NANOTECHNOLOGY AND NANOTOXICOLOGY; INDEX; Color plate |
Record Nr. | UNINA-9910785365203321 |
Hoboken, N.J., : John Wiley, c2011 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Cardiovascular effects of inhaled ultrafine and nanosized particles / / edited by Flemming R. Cassee, Nicholas L. Mills, David Newby |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Hoboken, N.J., : John Wiley, c2011 |
Descrizione fisica | 1 online resource (608 p.) |
Disciplina | 616.1/2071 |
Altri autori (Persone) |
CasseeFlemming R
MillsNicholas L NewbyDavid E |
Soggetto topico |
Heart - Toxicology
Air - Pollution - Toxicology Nanoparticles - Toxicology Pulmonary toxicology |
ISBN |
0-470-92277-X
1-282-88900-1 9786612889004 0-470-91091-7 0-470-91090-9 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
CARDIOVASCULAR EFFECTS OF INHALED ULTRAFINE AND NANOSIZED PARTICLES; CONTENTS; FOREWORD; PREFACE; THE EDITORS; CONTRIBUTORS; PART I: ISSUE FRAMING; CHAPTER 1: OVERVIEW; CHAPTER 2: ACUTE EFFECTS OF PARTICULATE MATTER ON THE RISK OF MYOCARDIAL INFARCTION; CHAPTER 3: CHRONIC EFFECTS OF AIR POLLUTION ON CARDIOVASCULAR HEALTH; PART II: EXPOSURE; CHAPTER 4: PARTICLE CHARACTERIZATION; CHAPTER 5: EXPOSURE ASSESSMENT FOR AMBIENT ULTRAFINE PARTICLES; CHAPTER 6: FROM EXPOSURE TO DOSE; CHAPTER 7: TRANSLOCATION OF INHALED NANOPARTICLES
CHAPTER 8: ROLE OF CHEMICAL COMPOSITION IN DETERMINING THE CARDIOVASCULAR EFFECTS OF PARTICLESPART III: METHODOLOGY; CHAPTER 9: IN VITRO STUDIES; CHAPTER 10: EXPERIMENTAL STUDIES IN ANIMALS; CHAPTER 11: HUMAN EXPOSURE STUDIES; CHAPTER 12: PANEL STUDIES; PART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS A. ATHEROGENESIS; CHAPTER 13: PARTICULATES AND OXIDATIVE STRESS; CHAPTER 14: ROLE OF INFLAMMATION IN THE ATHEROGENIC EFFECTS OF PARTICULATE MATTER; CHAPTER 15: INHALED PARTICLES, POSTPRANDIAL LIPIDS, AND THEIR POSSIBLE CONTRIBUTION TO ATHEROGENESIS: THE TROJAN HORSE HYPOTHESIS CHAPTER 16: INHALED PARTICULATE MATTER AND ATHEROSCLEROSIS IN HUMANSPART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS B. VASCULAR DYSFUNCTION; CHAPTER 17: EFFECTS OF NANOPARTICLES ON THE PULMONARY VASCULATURE; CHAPTER 18: PARTICULATE MATTER, HYPERTENSION, AND THE METABOLIC SYNDROME; CHAPTER 19: PARTICLES AND THE VASCULAR ENDOTHELIUM; PART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS C. THROMBOSIS; CHAPTER 20: PARTICLES, COAGULATION, AND THROMBOSIS; CHAPTER 21: PARTICLES AND THE PATHOGENESIS OF ATHEROTHROMBOSIS PART IV: PARTICLES AND CARDIOVASCULAR DISEASE: MECHANISMS D. ARRHYTHMIACHAPTER 22: PARTICLES AND THE AUTONOMIC NERVOUS SYSTEM; CHAPTER 23: AIR POLLUTION AND ARRHYTHMIA; PART V: ENVIRONMENTAL AND PUBLIC HEALTH POLICY; CHAPTER 24: RISK ASSESSMENT; CHAPTER 25: ENVIRONMENTAL REGULATION OF PARTICULATE MATTER; CHAPTER 26: FROM AMBIENT ULTRAFINE PARTICLES TO NANOTECHNOLOGY AND NANOTOXICOLOGY; INDEX; Color plate |
Record Nr. | UNINA-9910815463403321 |
Hoboken, N.J., : John Wiley, c2011 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|